
|Videos|March 30, 2021
Targeting PSMA in Advanced Prostate Cancer
Author(s)Ulka Vaishampayan, MD, Oliver Sartor, MD
Experts in genitourinary oncology discuss emerging research surrounding the clinical utility of phenotypic biomarkers, such as prostate-specific membrane antigen (PSMA), for use in the treatment of metastatic castration-resistant prostate cancer.



































